Linac-Pet Scan Opco Limited
- Address
- Nikis Avenue 1, 4108 Limassol, Cyprus
Linac-Pet Scan Opco Limited - Advanced Oncology Research Center
Linac-Pet Scan Opco Limited is a specialized research facility focusing on cutting-edge cancer diagnostics and therapeutic interventions. The center demonstrates particular expertise in integrating advanced imaging technologies with novel treatment approaches, particularly in PSMA PET/CT imaging and radioligand therapy for prostate cancer, as well as precision oncology strategies across multiple cancer types.
- Prostate cancer theranostics using Lutetium-177-PSMA therapy for oligo-metastatic hormone-sensitive disease
- AI-driven personalized radiotherapy with ultra-hypofractionation and treatment de-intensification
- ER+/HER2- breast cancer research focusing on ctDNA monitoring and endocrine therapy optimization
- Immunotherapy combinations for advanced solid tumors
The center's research portfolio emphasizes personalized medicine approaches through the integration of molecular imaging, circulating tumor DNA analysis, and artificial intelligence systems. Their work in prostate-specific membrane antigen (PSMA) imaging spans both diagnostic and therapeutic applications, while their breast cancer studies leverage liquid biopsy technologies to guide treatment decisions. The facility's capabilities in combining advanced imaging with targeted therapies and immunotherapy position it at the forefront of precision oncology research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 4 other sites in Cyprus
Therapeutic Area Benchmark — Cyprus
Select a therapeutic area to compare against other sites in Cyprus.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Cyprus
Market Share
Country: Cyprus
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Linac-Pet Scan Opco Limited
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| EORTC 2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA) | Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi | Phase III | Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 18F-Psma-1007 | 1 | Unknown | 2020-07-27 | 2020-07-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.